A pair of proteins, YAP and TAZ, has been identified as conductors of bone development in the womb and could provide insight into genetic diseases such as osteogenesis imperfecta, known commonly as “brittle bone disease.”
Bipartisan Momentum: FDA’s Decision on MDMA Expected by August 11th
Eighty members of Congress from both parties have come together to send letters to President Joe Biden and the US Food and Drug Administration, urging
August 6, 2024